CeriBell, Inc. (CBLL:NASDAQ) closed at $27.13 on October 23, 2026, down 0.99% on the day. The stock trades 3.5% below its 52-week high of $28.11 and 150.0% above its 52-week low of $10.85. Over the past year, it gained 110.5%. CeriBell, Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, CBLL closed higher on 126 days (50%). Its best day was November 21, 2025 (+11.88%) and its worst was May 12, 2026 (-16.50%). The stock moved 10% or more in a single session 3 times. It opened at least 5% above the previous day's high 1 time.
CeriBell is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. We have developed the Ceribell System, a novel, point-of-care electroencephalography platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable, and rapidly deployable hardware with sophisticated artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. We are initially focused on becoming the standard of care for the detection and management of seizures in the acute care setting. The Ceribell System has been adopted by more than 450 active accounts, ranging from top academic centers to small community hospitals, and has been used to care for over 100,000 patients.
Find more stocks like CBLL with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.